nodes	percent_of_prediction	percent_of_DWPC	metapath
Felodipine—CYP3A7—Sorafenib—liver cancer	0.0879	0.168	CbGbCtD
Felodipine—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0879	0.168	CbGbCtD
Felodipine—CYP3A5—Sorafenib—liver cancer	0.0659	0.126	CbGbCtD
Felodipine—CYP2C8—Sorafenib—liver cancer	0.0634	0.121	CbGbCtD
Felodipine—CYP2C9—Sorafenib—liver cancer	0.0442	0.0843	CbGbCtD
Felodipine—ABCB1—Sorafenib—liver cancer	0.0429	0.0818	CbGbCtD
Felodipine—CYP2D6—Sorafenib—liver cancer	0.0404	0.0771	CbGbCtD
Felodipine—ABCB1—Doxorubicin—liver cancer	0.026	0.0496	CbGbCtD
Felodipine—CYP3A4—Sorafenib—liver cancer	0.0257	0.049	CbGbCtD
Felodipine—CYP2D6—Doxorubicin—liver cancer	0.0245	0.0468	CbGbCtD
Felodipine—CYP3A4—Doxorubicin—liver cancer	0.0156	0.0297	CbGbCtD
Felodipine—Allergic cutaneous angiitis—Sorafenib—liver cancer	0.00851	0.0693	CcSEcCtD
Felodipine—Leukocytoclastic vasculitis—Sorafenib—liver cancer	0.00552	0.045	CcSEcCtD
Felodipine—Rhinorrhoea—Sorafenib—liver cancer	0.00334	0.0272	CcSEcCtD
Felodipine—Nimodipine—AHR—liver cancer	0.00328	0.385	CrCbGaD
Felodipine—Influenza like illness—Sorafenib—liver cancer	0.00263	0.0214	CcSEcCtD
Felodipine—Gynaecomastia—Sorafenib—liver cancer	0.00242	0.0197	CcSEcCtD
Felodipine—Erythema nodosum—Epirubicin—liver cancer	0.00231	0.0188	CcSEcCtD
Felodipine—Erythema nodosum—Doxorubicin—liver cancer	0.00214	0.0174	CcSEcCtD
Felodipine—Pain in extremity—Sorafenib—liver cancer	0.00196	0.016	CcSEcCtD
Felodipine—Nasopharyngitis—Sorafenib—liver cancer	0.00176	0.0143	CcSEcCtD
Felodipine—Abdominal discomfort—Sorafenib—liver cancer	0.00163	0.0133	CcSEcCtD
Felodipine—Erectile dysfunction—Sorafenib—liver cancer	0.00156	0.0127	CcSEcCtD
Felodipine—Epistaxis—Sorafenib—liver cancer	0.00143	0.0116	CcSEcCtD
Felodipine—Erythema multiforme—Sorafenib—liver cancer	0.00129	0.0105	CcSEcCtD
Felodipine—Feeling hot—Epirubicin—liver cancer	0.00127	0.0104	CcSEcCtD
Felodipine—Flushing—Sorafenib—liver cancer	0.00126	0.0103	CcSEcCtD
Felodipine—Arrhythmia—Sorafenib—liver cancer	0.00121	0.00989	CcSEcCtD
Felodipine—Erythema—Sorafenib—liver cancer	0.00118	0.00964	CcSEcCtD
Felodipine—Feeling hot—Doxorubicin—liver cancer	0.00118	0.00961	CcSEcCtD
Felodipine—Vasodilation procedure—Epirubicin—liver cancer	0.00114	0.00927	CcSEcCtD
Felodipine—Vasodilation—Epirubicin—liver cancer	0.00114	0.00927	CcSEcCtD
Felodipine—Muscle spasms—Sorafenib—liver cancer	0.00114	0.00927	CcSEcCtD
Felodipine—Clevidipine—CYP2E1—liver cancer	0.00111	0.131	CrCbGaD
Felodipine—Anaemia—Sorafenib—liver cancer	0.00109	0.00891	CcSEcCtD
Felodipine—Angioedema—Sorafenib—liver cancer	0.00108	0.00881	CcSEcCtD
Felodipine—Syncope—Sorafenib—liver cancer	0.00106	0.00864	CcSEcCtD
Felodipine—Vasodilation—Doxorubicin—liver cancer	0.00105	0.00858	CcSEcCtD
Felodipine—Vasodilation procedure—Doxorubicin—liver cancer	0.00105	0.00858	CcSEcCtD
Felodipine—Loss of consciousness—Sorafenib—liver cancer	0.00104	0.00847	CcSEcCtD
Felodipine—Cough—Sorafenib—liver cancer	0.00103	0.00841	CcSEcCtD
Felodipine—Arthralgia—Sorafenib—liver cancer	0.00101	0.00821	CcSEcCtD
Felodipine—Myalgia—Sorafenib—liver cancer	0.00101	0.00821	CcSEcCtD
Felodipine—Nilvadipine—CYP2E1—liver cancer	0.000998	0.117	CrCbGaD
Felodipine—Dry mouth—Sorafenib—liver cancer	0.000985	0.00802	CcSEcCtD
Felodipine—Influenza like illness—Epirubicin—liver cancer	0.000972	0.00791	CcSEcCtD
Felodipine—Shock—Sorafenib—liver cancer	0.00095	0.00774	CcSEcCtD
Felodipine—Influenza like illness—Doxorubicin—liver cancer	0.000899	0.00732	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00088	0.00717	CcSEcCtD
Felodipine—Dyspnoea—Sorafenib—liver cancer	0.000861	0.00701	CcSEcCtD
Felodipine—Dyspepsia—Sorafenib—liver cancer	0.00085	0.00692	CcSEcCtD
Felodipine—Amlodipine—CYP1A1—liver cancer	0.000848	0.0995	CrCbGaD
Felodipine—Fatigue—Sorafenib—liver cancer	0.000833	0.00678	CcSEcCtD
Felodipine—Constipation—Sorafenib—liver cancer	0.000826	0.00673	CcSEcCtD
Felodipine—Gastrointestinal pain—Sorafenib—liver cancer	0.00079	0.00643	CcSEcCtD
Felodipine—Nifedipine—CYP2E1—liver cancer	0.000769	0.0902	CrCbGaD
Felodipine—Urticaria—Sorafenib—liver cancer	0.000767	0.00625	CcSEcCtD
Felodipine—Body temperature increased—Sorafenib—liver cancer	0.000763	0.00622	CcSEcCtD
Felodipine—Abdominal pain—Sorafenib—liver cancer	0.000763	0.00622	CcSEcCtD
Felodipine—Nifedipine—CYP1A1—liver cancer	0.000758	0.089	CrCbGaD
Felodipine—Nicardipine—CYP2E1—liver cancer	0.000757	0.0888	CrCbGaD
Felodipine—Cerebrovascular accident—Epirubicin—liver cancer	0.000741	0.00604	CcSEcCtD
Felodipine—Pain in extremity—Epirubicin—liver cancer	0.000726	0.00591	CcSEcCtD
Felodipine—Hypersensitivity—Sorafenib—liver cancer	0.000712	0.0058	CcSEcCtD
Felodipine—Face oedema—Epirubicin—liver cancer	0.000701	0.00571	CcSEcCtD
Felodipine—Asthenia—Sorafenib—liver cancer	0.000693	0.00564	CcSEcCtD
Felodipine—Cerebrovascular accident—Doxorubicin—liver cancer	0.000686	0.00558	CcSEcCtD
Felodipine—Pruritus—Sorafenib—liver cancer	0.000683	0.00557	CcSEcCtD
Felodipine—Pain in extremity—Doxorubicin—liver cancer	0.000672	0.00547	CcSEcCtD
Felodipine—Orthostatic hypotension—Epirubicin—liver cancer	0.000663	0.0054	CcSEcCtD
Felodipine—Diarrhoea—Sorafenib—liver cancer	0.000661	0.00538	CcSEcCtD
Felodipine—Nasopharyngitis—Epirubicin—liver cancer	0.000649	0.00529	CcSEcCtD
Felodipine—Face oedema—Doxorubicin—liver cancer	0.000649	0.00528	CcSEcCtD
Felodipine—Dizziness—Sorafenib—liver cancer	0.000639	0.0052	CcSEcCtD
Felodipine—Influenza—Epirubicin—liver cancer	0.000628	0.00511	CcSEcCtD
Felodipine—Vomiting—Sorafenib—liver cancer	0.000614	0.005	CcSEcCtD
Felodipine—Orthostatic hypotension—Doxorubicin—liver cancer	0.000614	0.005	CcSEcCtD
Felodipine—Angina pectoris—Epirubicin—liver cancer	0.000611	0.00498	CcSEcCtD
Felodipine—Rash—Sorafenib—liver cancer	0.000609	0.00496	CcSEcCtD
Felodipine—Dermatitis—Sorafenib—liver cancer	0.000608	0.00495	CcSEcCtD
Felodipine—Headache—Sorafenib—liver cancer	0.000605	0.00493	CcSEcCtD
Felodipine—Bronchitis—Epirubicin—liver cancer	0.000604	0.00492	CcSEcCtD
Felodipine—Nasopharyngitis—Doxorubicin—liver cancer	0.000601	0.00489	CcSEcCtD
Felodipine—Dysuria—Epirubicin—liver cancer	0.000587	0.00478	CcSEcCtD
Felodipine—Upper respiratory tract infection—Epirubicin—liver cancer	0.000583	0.00475	CcSEcCtD
Felodipine—Influenza—Doxorubicin—liver cancer	0.000581	0.00473	CcSEcCtD
Felodipine—Pollakiuria—Epirubicin—liver cancer	0.00058	0.00472	CcSEcCtD
Felodipine—Nausea—Sorafenib—liver cancer	0.000574	0.00467	CcSEcCtD
Felodipine—Photosensitivity reaction—Epirubicin—liver cancer	0.000573	0.00467	CcSEcCtD
Felodipine—Angina pectoris—Doxorubicin—liver cancer	0.000566	0.00461	CcSEcCtD
Felodipine—Bronchitis—Doxorubicin—liver cancer	0.000558	0.00455	CcSEcCtD
Felodipine—Dysuria—Doxorubicin—liver cancer	0.000543	0.00442	CcSEcCtD
Felodipine—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00054	0.0044	CcSEcCtD
Felodipine—Pollakiuria—Doxorubicin—liver cancer	0.000536	0.00437	CcSEcCtD
Felodipine—Photosensitivity reaction—Doxorubicin—liver cancer	0.00053	0.00432	CcSEcCtD
Felodipine—Epistaxis—Epirubicin—liver cancer	0.000528	0.0043	CcSEcCtD
Felodipine—Sinusitis—Epirubicin—liver cancer	0.000525	0.00428	CcSEcCtD
Felodipine—Bradycardia—Epirubicin—liver cancer	0.000511	0.00417	CcSEcCtD
Felodipine—Pharyngitis—Epirubicin—liver cancer	0.000499	0.00406	CcSEcCtD
Felodipine—Oedema peripheral—Epirubicin—liver cancer	0.000495	0.00403	CcSEcCtD
Felodipine—Epistaxis—Doxorubicin—liver cancer	0.000488	0.00398	CcSEcCtD
Felodipine—Sinusitis—Doxorubicin—liver cancer	0.000486	0.00396	CcSEcCtD
Felodipine—Visual impairment—Epirubicin—liver cancer	0.000484	0.00394	CcSEcCtD
Felodipine—Erythema multiforme—Epirubicin—liver cancer	0.000475	0.00387	CcSEcCtD
Felodipine—Bradycardia—Doxorubicin—liver cancer	0.000473	0.00385	CcSEcCtD
Felodipine—Flushing—Epirubicin—liver cancer	0.000466	0.0038	CcSEcCtD
Felodipine—Pharyngitis—Doxorubicin—liver cancer	0.000461	0.00376	CcSEcCtD
Felodipine—Oedema peripheral—Doxorubicin—liver cancer	0.000458	0.00373	CcSEcCtD
Felodipine—Arrhythmia—Epirubicin—liver cancer	0.000449	0.00366	CcSEcCtD
Felodipine—Visual impairment—Doxorubicin—liver cancer	0.000448	0.00365	CcSEcCtD
Felodipine—Erythema multiforme—Doxorubicin—liver cancer	0.000439	0.00358	CcSEcCtD
Felodipine—Erythema—Epirubicin—liver cancer	0.000437	0.00356	CcSEcCtD
Felodipine—Flushing—Doxorubicin—liver cancer	0.000431	0.00351	CcSEcCtD
Felodipine—Flatulence—Epirubicin—liver cancer	0.000431	0.00351	CcSEcCtD
Felodipine—Tension—Epirubicin—liver cancer	0.000429	0.0035	CcSEcCtD
Felodipine—Nervousness—Epirubicin—liver cancer	0.000425	0.00346	CcSEcCtD
Felodipine—Back pain—Epirubicin—liver cancer	0.000423	0.00345	CcSEcCtD
Felodipine—Muscle spasms—Epirubicin—liver cancer	0.00042	0.00342	CcSEcCtD
Felodipine—Arrhythmia—Doxorubicin—liver cancer	0.000415	0.00338	CcSEcCtD
Felodipine—Erythema—Doxorubicin—liver cancer	0.000405	0.0033	CcSEcCtD
Felodipine—Anaemia—Epirubicin—liver cancer	0.000404	0.00329	CcSEcCtD
Felodipine—Flatulence—Doxorubicin—liver cancer	0.000399	0.00325	CcSEcCtD
Felodipine—Tension—Doxorubicin—liver cancer	0.000397	0.00323	CcSEcCtD
Felodipine—Nervousness—Doxorubicin—liver cancer	0.000393	0.0032	CcSEcCtD
Felodipine—Vertigo—Epirubicin—liver cancer	0.000393	0.0032	CcSEcCtD
Felodipine—Syncope—Epirubicin—liver cancer	0.000392	0.00319	CcSEcCtD
Felodipine—Back pain—Doxorubicin—liver cancer	0.000391	0.00319	CcSEcCtD
Felodipine—Muscle spasms—Doxorubicin—liver cancer	0.000389	0.00317	CcSEcCtD
Felodipine—Palpitations—Epirubicin—liver cancer	0.000386	0.00315	CcSEcCtD
Felodipine—Loss of consciousness—Epirubicin—liver cancer	0.000384	0.00313	CcSEcCtD
Felodipine—Cough—Epirubicin—liver cancer	0.000382	0.00311	CcSEcCtD
Felodipine—Anaemia—Doxorubicin—liver cancer	0.000374	0.00305	CcSEcCtD
Felodipine—Chest pain—Epirubicin—liver cancer	0.000372	0.00303	CcSEcCtD
Felodipine—Myalgia—Epirubicin—liver cancer	0.000372	0.00303	CcSEcCtD
Felodipine—Arthralgia—Epirubicin—liver cancer	0.000372	0.00303	CcSEcCtD
Felodipine—Dry mouth—Epirubicin—liver cancer	0.000364	0.00297	CcSEcCtD
Felodipine—Vertigo—Doxorubicin—liver cancer	0.000364	0.00296	CcSEcCtD
Felodipine—Syncope—Doxorubicin—liver cancer	0.000363	0.00296	CcSEcCtD
Felodipine—Confusional state—Epirubicin—liver cancer	0.00036	0.00293	CcSEcCtD
Felodipine—Palpitations—Doxorubicin—liver cancer	0.000358	0.00291	CcSEcCtD
Felodipine—Loss of consciousness—Doxorubicin—liver cancer	0.000356	0.0029	CcSEcCtD
Felodipine—Cough—Doxorubicin—liver cancer	0.000353	0.00288	CcSEcCtD
Felodipine—Shock—Epirubicin—liver cancer	0.000351	0.00286	CcSEcCtD
Felodipine—Tachycardia—Epirubicin—liver cancer	0.000348	0.00284	CcSEcCtD
Felodipine—Chest pain—Doxorubicin—liver cancer	0.000344	0.00281	CcSEcCtD
Felodipine—Myalgia—Doxorubicin—liver cancer	0.000344	0.00281	CcSEcCtD
Felodipine—Arthralgia—Doxorubicin—liver cancer	0.000344	0.00281	CcSEcCtD
Felodipine—Dry mouth—Doxorubicin—liver cancer	0.000337	0.00274	CcSEcCtD
Felodipine—Confusional state—Doxorubicin—liver cancer	0.000333	0.00271	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000325	0.00265	CcSEcCtD
Felodipine—Shock—Doxorubicin—liver cancer	0.000325	0.00265	CcSEcCtD
Felodipine—Insomnia—Epirubicin—liver cancer	0.000323	0.00263	CcSEcCtD
Felodipine—Tachycardia—Doxorubicin—liver cancer	0.000322	0.00263	CcSEcCtD
Felodipine—Paraesthesia—Epirubicin—liver cancer	0.00032	0.00261	CcSEcCtD
Felodipine—Dyspnoea—Epirubicin—liver cancer	0.000318	0.00259	CcSEcCtD
Felodipine—Somnolence—Epirubicin—liver cancer	0.000317	0.00258	CcSEcCtD
Felodipine—Dyspepsia—Epirubicin—liver cancer	0.000314	0.00256	CcSEcCtD
Felodipine—Fatigue—Epirubicin—liver cancer	0.000308	0.00251	CcSEcCtD
Felodipine—Constipation—Epirubicin—liver cancer	0.000305	0.00249	CcSEcCtD
Felodipine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000301	0.00245	CcSEcCtD
Felodipine—Insomnia—Doxorubicin—liver cancer	0.000299	0.00243	CcSEcCtD
Felodipine—Paraesthesia—Doxorubicin—liver cancer	0.000297	0.00242	CcSEcCtD
Felodipine—Dyspnoea—Doxorubicin—liver cancer	0.000294	0.0024	CcSEcCtD
Felodipine—Feeling abnormal—Epirubicin—liver cancer	0.000294	0.0024	CcSEcCtD
Felodipine—Somnolence—Doxorubicin—liver cancer	0.000294	0.00239	CcSEcCtD
Felodipine—Gastrointestinal pain—Epirubicin—liver cancer	0.000292	0.00238	CcSEcCtD
Felodipine—Dyspepsia—Doxorubicin—liver cancer	0.000291	0.00237	CcSEcCtD
Felodipine—Fatigue—Doxorubicin—liver cancer	0.000285	0.00232	CcSEcCtD
Felodipine—Urticaria—Epirubicin—liver cancer	0.000284	0.00231	CcSEcCtD
Felodipine—Constipation—Doxorubicin—liver cancer	0.000282	0.0023	CcSEcCtD
Felodipine—Abdominal pain—Epirubicin—liver cancer	0.000282	0.0023	CcSEcCtD
Felodipine—Body temperature increased—Epirubicin—liver cancer	0.000282	0.0023	CcSEcCtD
Felodipine—Feeling abnormal—Doxorubicin—liver cancer	0.000272	0.00222	CcSEcCtD
Felodipine—Gastrointestinal pain—Doxorubicin—liver cancer	0.00027	0.0022	CcSEcCtD
Felodipine—Hypersensitivity—Epirubicin—liver cancer	0.000263	0.00214	CcSEcCtD
Felodipine—Urticaria—Doxorubicin—liver cancer	0.000262	0.00214	CcSEcCtD
Felodipine—Abdominal pain—Doxorubicin—liver cancer	0.000261	0.00213	CcSEcCtD
Felodipine—Body temperature increased—Doxorubicin—liver cancer	0.000261	0.00213	CcSEcCtD
Felodipine—Asthenia—Epirubicin—liver cancer	0.000256	0.00209	CcSEcCtD
Felodipine—Pruritus—Epirubicin—liver cancer	0.000253	0.00206	CcSEcCtD
Felodipine—Diarrhoea—Epirubicin—liver cancer	0.000244	0.00199	CcSEcCtD
Felodipine—Hypersensitivity—Doxorubicin—liver cancer	0.000243	0.00198	CcSEcCtD
Felodipine—Asthenia—Doxorubicin—liver cancer	0.000237	0.00193	CcSEcCtD
Felodipine—Dizziness—Epirubicin—liver cancer	0.000236	0.00192	CcSEcCtD
Felodipine—Pruritus—Doxorubicin—liver cancer	0.000234	0.0019	CcSEcCtD
Felodipine—Vomiting—Epirubicin—liver cancer	0.000227	0.00185	CcSEcCtD
Felodipine—Diarrhoea—Doxorubicin—liver cancer	0.000226	0.00184	CcSEcCtD
Felodipine—Rash—Epirubicin—liver cancer	0.000225	0.00183	CcSEcCtD
Felodipine—Dermatitis—Epirubicin—liver cancer	0.000225	0.00183	CcSEcCtD
Felodipine—Headache—Epirubicin—liver cancer	0.000224	0.00182	CcSEcCtD
Felodipine—Dizziness—Doxorubicin—liver cancer	0.000218	0.00178	CcSEcCtD
Felodipine—Nausea—Epirubicin—liver cancer	0.000212	0.00173	CcSEcCtD
Felodipine—Vomiting—Doxorubicin—liver cancer	0.00021	0.00171	CcSEcCtD
Felodipine—Rash—Doxorubicin—liver cancer	0.000208	0.0017	CcSEcCtD
Felodipine—Dermatitis—Doxorubicin—liver cancer	0.000208	0.00169	CcSEcCtD
Felodipine—Headache—Doxorubicin—liver cancer	0.000207	0.00169	CcSEcCtD
Felodipine—Nausea—Doxorubicin—liver cancer	0.000196	0.0016	CcSEcCtD
Felodipine—CALM1—Immune System—IL2—liver cancer	9.29e-06	2.7e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—IL2—liver cancer	9.29e-06	2.7e-05	CbGpPWpGaD
Felodipine—PDE1A—Signaling Pathways—AKT1—liver cancer	9.29e-06	2.7e-05	CbGpPWpGaD
Felodipine—CALM3—Metabolism—PIK3CD—liver cancer	9.28e-06	2.7e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—CTNNB1—liver cancer	9.28e-06	2.69e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—KDR—liver cancer	9.27e-06	2.69e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—KDR—liver cancer	9.27e-06	2.69e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—F2—liver cancer	9.22e-06	2.68e-05	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—IL6—liver cancer	9.21e-06	2.67e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MAPK14—liver cancer	9.21e-06	2.67e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MAPK14—liver cancer	9.21e-06	2.67e-05	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—ALB—liver cancer	9.2e-06	2.67e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—PIK3CG—liver cancer	9.18e-06	2.67e-05	CbGpPWpGaD
Felodipine—CALM3—Metabolism—ALB—liver cancer	9.16e-06	2.66e-05	CbGpPWpGaD
Felodipine—CACNA1C—Metabolism—AKT1—liver cancer	9.14e-06	2.65e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—CDKN1B—liver cancer	9.07e-06	2.63e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—CDKN1A—liver cancer	9.06e-06	2.63e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—JUN—liver cancer	9.04e-06	2.63e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—JUN—liver cancer	9.04e-06	2.63e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—ESR1—liver cancer	9.03e-06	2.62e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—ESR1—liver cancer	9.03e-06	2.62e-05	CbGpPWpGaD
Felodipine—CALM1—Metabolism—PIK3CD—liver cancer	8.98e-06	2.61e-05	CbGpPWpGaD
Felodipine—CALM2—Metabolism—PIK3CD—liver cancer	8.98e-06	2.61e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—MTHFR—liver cancer	8.97e-06	2.61e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—CTNNB1—liver cancer	8.97e-06	2.61e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—CTNNB1—liver cancer	8.97e-06	2.61e-05	CbGpPWpGaD
Felodipine—CALM3—Innate Immune System—AKT1—liver cancer	8.95e-06	2.6e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—F2—liver cancer	8.92e-06	2.59e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—F2—liver cancer	8.92e-06	2.59e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—MTHFR—liver cancer	8.9e-06	2.58e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—PPARG—liver cancer	8.86e-06	2.57e-05	CbGpPWpGaD
Felodipine—CALM2—Metabolism—ALB—liver cancer	8.86e-06	2.57e-05	CbGpPWpGaD
Felodipine—CALM1—Metabolism—ALB—liver cancer	8.86e-06	2.57e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—MAPK8—liver cancer	8.84e-06	2.57e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—PIK3CG—liver cancer	8.83e-06	2.56e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—APC—liver cancer	8.83e-06	2.56e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PPARA—liver cancer	8.8e-06	2.56e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—CDKN1B—liver cancer	8.77e-06	2.55e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—CDKN1B—liver cancer	8.77e-06	2.55e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—CDKN1A—liver cancer	8.77e-06	2.55e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—CDKN1A—liver cancer	8.77e-06	2.55e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—CYP2E1—liver cancer	8.76e-06	2.54e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PPARA—liver cancer	8.73e-06	2.53e-05	CbGpPWpGaD
Felodipine—CALM2—Innate Immune System—AKT1—liver cancer	8.65e-06	2.51e-05	CbGpPWpGaD
Felodipine—CALM1—Innate Immune System—AKT1—liver cancer	8.65e-06	2.51e-05	CbGpPWpGaD
Felodipine—CALM3—Adaptive Immune System—AKT1—liver cancer	8.59e-06	2.49e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—CTNNB1—liver cancer	8.56e-06	2.49e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—MAPK8—liver cancer	8.56e-06	2.48e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—MAPK8—liver cancer	8.56e-06	2.48e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—PIK3CG—liver cancer	8.54e-06	2.48e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—APC—liver cancer	8.54e-06	2.48e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—PIK3CG—liver cancer	8.54e-06	2.48e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—APC—liver cancer	8.54e-06	2.48e-05	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—AKT1—liver cancer	8.5e-06	2.47e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—CDKN1A—liver cancer	8.37e-06	2.43e-05	CbGpPWpGaD
Felodipine—CALM1—Adaptive Immune System—AKT1—liver cancer	8.31e-06	2.41e-05	CbGpPWpGaD
Felodipine—CALM2—Adaptive Immune System—AKT1—liver cancer	8.31e-06	2.41e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—BRAF—liver cancer	8.3e-06	2.41e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—CTNNB1—liver cancer	8.28e-06	2.41e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—CTNNB1—liver cancer	8.28e-06	2.41e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—CYCS—liver cancer	8.2e-06	2.38e-05	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—PIK3CB—liver cancer	8.12e-06	2.36e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—CDKN1A—liver cancer	8.09e-06	2.35e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—CDKN1A—liver cancer	8.09e-06	2.35e-05	CbGpPWpGaD
Felodipine—CALM3—Metabolism—PIK3CB—liver cancer	8.09e-06	2.35e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—STAT3—liver cancer	8.09e-06	2.35e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—PIK3CD—liver cancer	8.07e-06	2.34e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—GOT1—liver cancer	8.04e-06	2.34e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—GGT1—liver cancer	8.04e-06	2.34e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—BRAF—liver cancer	8.03e-06	2.33e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—BRAF—liver cancer	8.03e-06	2.33e-05	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PIK3CG—liver cancer	8e-06	2.32e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—ALB—liver cancer	7.97e-06	2.31e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.84e-06	2.28e-05	CbGpPWpGaD
Felodipine—CALM2—Metabolism—PIK3CB—liver cancer	7.83e-06	2.27e-05	CbGpPWpGaD
Felodipine—CALM1—Metabolism—PIK3CB—liver cancer	7.83e-06	2.27e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—STAT3—liver cancer	7.82e-06	2.27e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—STAT3—liver cancer	7.82e-06	2.27e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—PIK3CD—liver cancer	7.76e-06	2.25e-05	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PPARG—liver cancer	7.72e-06	2.24e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—SERPINE1—liver cancer	7.68e-06	2.23e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—KRAS—liver cancer	7.6e-06	2.21e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PIK3CG—liver cancer	7.54e-06	2.19e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—PIK3CD—liver cancer	7.51e-06	2.18e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—PIK3CD—liver cancer	7.51e-06	2.18e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PIK3CG—liver cancer	7.47e-06	2.17e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—STAT3—liver cancer	7.47e-06	2.17e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—SERPINE1—liver cancer	7.43e-06	2.16e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—SERPINE1—liver cancer	7.43e-06	2.16e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—KRAS—liver cancer	7.35e-06	2.13e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—KRAS—liver cancer	7.35e-06	2.13e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PPARG—liver cancer	7.28e-06	2.11e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—GSTP1—liver cancer	7.22e-06	2.1e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—STAT3—liver cancer	7.22e-06	2.1e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—STAT3—liver cancer	7.22e-06	2.1e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PPARG—liver cancer	7.21e-06	2.1e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—HMOX1—liver cancer	7.12e-06	2.07e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—PIK3CB—liver cancer	7.04e-06	2.04e-05	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PIK3CD—liver cancer	7.03e-06	2.04e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—PIK3CA—liver cancer	6.98e-06	2.03e-05	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—ALB—liver cancer	6.94e-06	2.02e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—KRAS—liver cancer	6.94e-06	2.02e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—MYC—liver cancer	6.94e-06	2.01e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—RAF1—liver cancer	6.93e-06	2.01e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—TGFB1—liver cancer	6.92e-06	2.01e-05	CbGpPWpGaD
Felodipine—CYP3A7—Metabolism—PIK3CA—liver cancer	6.85e-06	1.99e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MTOR—liver cancer	6.76e-06	1.96e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—PIK3CB—liver cancer	6.76e-06	1.96e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—PIK3CA—liver cancer	6.75e-06	1.96e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—PIK3CA—liver cancer	6.75e-06	1.96e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—KRAS—liver cancer	6.72e-06	1.95e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—KRAS—liver cancer	6.72e-06	1.95e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—MYC—liver cancer	6.71e-06	1.95e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—MYC—liver cancer	6.71e-06	1.95e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—RAF1—liver cancer	6.7e-06	1.95e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—RAF1—liver cancer	6.7e-06	1.95e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—TGFB1—liver cancer	6.69e-06	1.94e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—TGFB1—liver cancer	6.69e-06	1.94e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—GSTM1—liver cancer	6.64e-06	1.93e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PIK3CD—liver cancer	6.63e-06	1.92e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PIK3CD—liver cancer	6.57e-06	1.91e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MTOR—liver cancer	6.54e-06	1.9e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—PIK3CB—liver cancer	6.54e-06	1.9e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MTOR—liver cancer	6.54e-06	1.9e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—PIK3CB—liver cancer	6.54e-06	1.9e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—ALB—liver cancer	6.54e-06	1.9e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—ALB—liver cancer	6.49e-06	1.88e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—HRAS—liver cancer	6.46e-06	1.88e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—KRAS—liver cancer	6.41e-06	1.86e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—PIK3CA—liver cancer	6.38e-06	1.85e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CDKN1B—liver cancer	6.35e-06	1.84e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—CYP1A1—liver cancer	6.29e-06	1.83e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—HRAS—liver cancer	6.25e-06	1.81e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—HRAS—liver cancer	6.25e-06	1.81e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CASP3—liver cancer	6.22e-06	1.81e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—IL2—liver cancer	6.21e-06	1.8e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—KRAS—liver cancer	6.2e-06	1.8e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—KRAS—liver cancer	6.2e-06	1.8e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—IL6—liver cancer	6.18e-06	1.8e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—PIK3CA—liver cancer	6.17e-06	1.79e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—PIK3CA—liver cancer	6.17e-06	1.79e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CDKN1B—liver cancer	6.14e-06	1.78e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CDKN1B—liver cancer	6.14e-06	1.78e-05	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PIK3CB—liver cancer	6.13e-06	1.78e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CCND1—liver cancer	6.06e-06	1.76e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—JUN—liver cancer	6.04e-06	1.76e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CASP3—liver cancer	6.02e-06	1.75e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CASP3—liver cancer	6.02e-06	1.75e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—IL2—liver cancer	6.01e-06	1.75e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—IL2—liver cancer	6.01e-06	1.75e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CTNNB1—liver cancer	6e-06	1.74e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—IL6—liver cancer	5.98e-06	1.74e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—IL6—liver cancer	5.98e-06	1.74e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—HRAS—liver cancer	5.9e-06	1.71e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—PIK3CA—liver cancer	5.89e-06	1.71e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MMP9—liver cancer	5.88e-06	1.71e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—MTHFR—liver cancer	5.87e-06	1.7e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CDKN1A—liver cancer	5.86e-06	1.7e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CCND1—liver cancer	5.86e-06	1.7e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CCND1—liver cancer	5.86e-06	1.7e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—JUN—liver cancer	5.85e-06	1.7e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—JUN—liver cancer	5.85e-06	1.7e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CTNNB1—liver cancer	5.8e-06	1.68e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CTNNB1—liver cancer	5.8e-06	1.68e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PIK3CB—liver cancer	5.78e-06	1.68e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PPARA—liver cancer	5.76e-06	1.67e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PIK3CB—liver cancer	5.73e-06	1.66e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MAPK8—liver cancer	5.72e-06	1.66e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—HRAS—liver cancer	5.71e-06	1.66e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—HRAS—liver cancer	5.71e-06	1.66e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—AKT1—liver cancer	5.7e-06	1.66e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—PIK3CA—liver cancer	5.7e-06	1.65e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—PIK3CA—liver cancer	5.7e-06	1.65e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MMP9—liver cancer	5.69e-06	1.65e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MMP9—liver cancer	5.69e-06	1.65e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CDKN1A—liver cancer	5.67e-06	1.65e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CDKN1A—liver cancer	5.67e-06	1.65e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—IL6—liver cancer	5.65e-06	1.64e-05	CbGpPWpGaD
Felodipine—CYP3A7—Metabolism—AKT1—liver cancer	5.6e-06	1.63e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MAPK8—liver cancer	5.53e-06	1.61e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MAPK8—liver cancer	5.53e-06	1.61e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—AKT1—liver cancer	5.52e-06	1.6e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—AKT1—liver cancer	5.52e-06	1.6e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—IL6—liver cancer	5.46e-06	1.59e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—IL6—liver cancer	5.46e-06	1.59e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—HRAS—liver cancer	5.45e-06	1.58e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—VEGFA—liver cancer	5.28e-06	1.53e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—HRAS—liver cancer	5.27e-06	1.53e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—HRAS—liver cancer	5.27e-06	1.53e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—STAT3—liver cancer	5.23e-06	1.52e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—IL6—liver cancer	5.21e-06	1.51e-05	CbGpPWpGaD
Felodipine—CALM3—Immune System—AKT1—liver cancer	5.21e-06	1.51e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—VEGFA—liver cancer	5.11e-06	1.48e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—VEGFA—liver cancer	5.11e-06	1.48e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—STAT3—liver cancer	5.06e-06	1.47e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—STAT3—liver cancer	5.06e-06	1.47e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—IL6—liver cancer	5.04e-06	1.46e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—IL6—liver cancer	5.04e-06	1.46e-05	CbGpPWpGaD
Felodipine—CALM2—Immune System—AKT1—liver cancer	5.04e-06	1.46e-05	CbGpPWpGaD
Felodipine—CALM1—Immune System—AKT1—liver cancer	5.04e-06	1.46e-05	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—PIK3CA—liver cancer	4.95e-06	1.44e-05	CbGpPWpGaD
Felodipine—CALM3—Metabolism—PIK3CA—liver cancer	4.93e-06	1.43e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PIK3CG—liver cancer	4.93e-06	1.43e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—MYC—liver cancer	4.86e-06	1.41e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—TGFB1—liver cancer	4.85e-06	1.41e-05	CbGpPWpGaD
Felodipine—CALM3—Disease—AKT1—liver cancer	4.81e-06	1.4e-05	CbGpPWpGaD
Felodipine—CALM2—Metabolism—PIK3CA—liver cancer	4.77e-06	1.39e-05	CbGpPWpGaD
Felodipine—CALM1—Metabolism—PIK3CA—liver cancer	4.77e-06	1.39e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PPARG—liver cancer	4.76e-06	1.38e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—MYC—liver cancer	4.7e-06	1.36e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—MYC—liver cancer	4.7e-06	1.36e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—TGFB1—liver cancer	4.69e-06	1.36e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—TGFB1—liver cancer	4.69e-06	1.36e-05	CbGpPWpGaD
Felodipine—CALM1—Disease—AKT1—liver cancer	4.65e-06	1.35e-05	CbGpPWpGaD
Felodipine—CALM2—Disease—AKT1—liver cancer	4.65e-06	1.35e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—KRAS—liver cancer	4.49e-06	1.3e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—KRAS—liver cancer	4.34e-06	1.26e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—KRAS—liver cancer	4.34e-06	1.26e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PIK3CD—liver cancer	4.33e-06	1.26e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—PIK3CA—liver cancer	4.29e-06	1.25e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—ALB—liver cancer	4.28e-06	1.24e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—PIK3CA—liver cancer	4.12e-06	1.2e-05	CbGpPWpGaD
Felodipine—CYP3A5—Metabolism—AKT1—liver cancer	4.05e-06	1.18e-05	CbGpPWpGaD
Felodipine—CALM3—Metabolism—AKT1—liver cancer	4.03e-06	1.17e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—TP53—liver cancer	3.99e-06	1.16e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—PIK3CA—liver cancer	3.99e-06	1.16e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—PIK3CA—liver cancer	3.99e-06	1.16e-05	CbGpPWpGaD
Felodipine—CALM1—Metabolism—AKT1—liver cancer	3.9e-06	1.13e-05	CbGpPWpGaD
Felodipine—CALM2—Metabolism—AKT1—liver cancer	3.9e-06	1.13e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—TP53—liver cancer	3.86e-06	1.12e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—TP53—liver cancer	3.86e-06	1.12e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—HRAS—liver cancer	3.82e-06	1.11e-05	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PIK3CB—liver cancer	3.78e-06	1.1e-05	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—PIK3CA—liver cancer	3.74e-06	1.09e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—HRAS—liver cancer	3.69e-06	1.07e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—HRAS—liver cancer	3.69e-06	1.07e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—IL6—liver cancer	3.65e-06	1.06e-05	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—IL6—liver cancer	3.53e-06	1.03e-05	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—IL6—liver cancer	3.53e-06	1.03e-05	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—PIK3CA—liver cancer	3.52e-06	1.02e-05	CbGpPWpGaD
Felodipine—CYP2C8—Metabolism—AKT1—liver cancer	3.5e-06	1.02e-05	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—PIK3CA—liver cancer	3.49e-06	1.01e-05	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—AKT1—liver cancer	3.37e-06	9.78e-06	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—AKT1—liver cancer	3.26e-06	9.46e-06	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—AKT1—liver cancer	3.26e-06	9.46e-06	CbGpPWpGaD
Felodipine—ABCB1—Metabolism—AKT1—liver cancer	3.05e-06	8.87e-06	CbGpPWpGaD
Felodipine—CYP2D6—Metabolism—AKT1—liver cancer	2.88e-06	8.36e-06	CbGpPWpGaD
Felodipine—CYP2C9—Metabolism—AKT1—liver cancer	2.85e-06	8.28e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—PIK3CA—liver cancer	2.3e-06	6.69e-06	CbGpPWpGaD
Felodipine—CYP3A4—Metabolism—AKT1—liver cancer	1.88e-06	5.46e-06	CbGpPWpGaD
